Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms

Kuan, J.W. and Lau, N.S. and Chang, K.M. and Tan, S.M. and Ong, T.C. and Purushothamany, V. (2019) Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms. Blood, 112 (11). p. 5013. ISSN 0006-4971

[img] PDF
Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell.pdf

Download (309kB)
Item Type: Article
Uncontrolled Keywords: alemtuzumab, hypercvad protocol, t-cell neoplasms, t-lymphocytes, leukemia, complete remission, leukemia, t-cell, lymphoma, single-dose regimen, cmv reactivation, unimas, university, universiti, Borneo, Malaysia, Sarawak, Kuching, Samarahan, ipta, education, research, Universiti Malaysia Sarawak
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Academic Faculties, Institutes and Centres > Faculty of Medicine and Health Sciences
Depositing User: Karen Kornalius
Date Deposited: 09 Jan 2020 07:57
Last Modified: 09 Jan 2020 07:57
URI: http://ir.unimas.my/id/eprint/28725

Actions (For repository members only: login required)

View Item View Item